Hans Schikan, CEO of Prosensa, on Rare Disease Drug Development
At the BIO CEO Investor Conference in New York, BIO had the opportunity to speak with Hans Schikan, CEO of Prosensa, a company that targets rare diseases -...
By:
Biotechnology Industry OrganizationRead more from the original source:
Hans Schikan, CEO of Prosensa, on Rare Disease Drug Development - Video
Recommendation and review posted by G. Smith